Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
DEKA Biosciences
DEKA Biosciences
Eli Lilly and Company
Actuate Therapeutics Inc.
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Children's Oncology Group
GlaxoSmithKline